共 50 条
- [42] Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) JOURNAL OF INVASIVE CARDIOLOGY, 2017, 29 (10): : 340 - 351
- [47] Contemporary Use of Prasugrel in Clinical Practice Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (03): : 293 - 298
- [48] ASSOCIATION OF ANEMIA WTH OUTCOMES IN PATIENTS UNDERGOING PERCUTANEOUS PERIPHERAL VASCULAR DISEASE INTERVENTION: INSIGHTS FROM THE BMC2 VIC (BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM VASCULAR INTERVENTIONS COLLABORATIVE) REGISTRY JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 311 - 311
- [49] The Epidemiology and Outcomes of Percutaneous Coronary Intervention Before High-Risk Noncardiac Surgery in Contemporary Practice: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (03):